News

On June 21st, Global LabTalk Forum was held in the Central Plains to discuss the development of global laboratory medicine technology and international cooperation. The conference, which was jointly organized by Autobio and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), attracted nearly 300 experts and scholars from more than 20 countries and regions around the world. The event took place at the Autobio IVD Industrial Park, where attendees gathered to discuss cutting-edge technologies and share the latest research results.

Mr. Miao Yongjun, Chairman of Autobio, delivered a speech at the seminar. He thoroughly analyzed the current state of the global in vitro diagnostics market, highlighting the significant impact of advancements in artificial intelligence and remote diagnostic technology on reshaping industry patterns. He also noted that the surge in demand for precision testing and the expansion of emerging markets have created unprecedented development opportunities for the industry. He emphasized that to seize development opportunities in the industry, we must embrace technological innovation, accelerate intelligent transformation, and optimize the quality management system. He stated that Autobio is accelerating the globalization layout, and its products have already served more than 100 countries and regions worldwide. In the future, Autobio will meet the diversified needs of global customers with better products and services, and help the development of global testing business.

During the special speech session, experts in the field of clinical and testing from home and abroad shared their experience in self-contained laboratory management and the latest research results.

Professor Tomris Ozben, the President of IFCC, provided insights on the evolution of laboratory medicine. She noted that the field of medicine is undergoing rapid advancements, particularly in the integration of artificial intelligence and big data analysis. These technological developments promise to enhance testing efficiency and transform the future of medical testing.

Professor Sergio Bernardini, Secretary General of IFCC, introduced the development history of laboratory medicine and the series of measures made by IFCC to promote laboratory management. He emphasized that IFCC will continue to promote international cooperation and exchange, helping global laboratory medicine reach a higher level. This will be achieved by improving global laboratory management through standardizing processes and quality control systems, promoting the accuracy and reliability of test results, and providing a solid foundation for clinical decision-making.

Dr. Salam AL Rashdi presented an overview of the structure and accreditation standards for medical laboratory services in Oman. He also shared insights on the current state and challenges of laboratory medicine in the Middle East, emphasizing the critical role of effective laboratory management in enhancing healthcare quality.

Dr. Saleh Alzahrani presented on the transformation of clinical laboratory operations, strategic adjustments in supply chain and procurement, and the importance of informatization around Saudi Arabia's Vision 2030. He emphasized the improvement of laboratory operational efficiency through technological innovation and process optimization.

Additionally, a number of distinguished experts from both domestic and international backgrounds shared their insights on the following subjects:

- The current status and advancements in circulating tumor cell detection

- Addressing challenges and devising practical solutions to immunoassay interference

- The role of glycoprotein targets in the diagnosis and prevention of tumors, infections, and autoimmune diseases

- The application of glycoprotein targets in the diagnosis and prevention of autoimmune diseases The following topics were discussed in depth: "Glycoprotein Targets in the Diagnosis and Prevention of Tumors, Infections, and Autoimmune Diseases" and "Prostate Specific Antigen (PSA) in Biochemistry."

Chen Fei, Director of the International Trade and Cooperation Center of Autobio, presented on the challenges and innovations in the testing industry and Autobio's work in international expansion.

Autobio Executive Vice President Fu Guangyu delivered the concluding statement. He noted that today's dynamic academic seminar and exchange of ideas have led to a more profound comprehension of the future trajectory of laboratory medicine. Additionally, it has underscored the significance of technological innovation and international collaboration. We hope that global partners will collaborate to advance the development of standardized, intelligent, and universal diagnostic technology, ensuring that precision medicine benefits all lives.

The International Federation of Clinical Chemistry (IFCC) was founded in 1952. It is a global authority in the fields of clinical chemistry and laboratory medicine. The IFCC has 119 national and regional members and more than 50,000 expert members. It plays a key role in global medical laboratory standardization, quality system construction, and cross-regional technical collaboration.

Autobio and IFCC recently collaborated to organize the Global Symposium on the Development of Laboratory Medicine. This event provided a platform for experts and scholars in the field of laboratory medicine from around the world to engage in high-level, cross-border, and interdisciplinary dialogues. The goal of the symposium was to facilitate knowledge sharing, stimulate the exchange of ideas, and encourage the advancement of testing technology to improve human health.